NeuroPace (NPCE) Short Interest Ratio & Short Volume $9.70 +0.70 (+7.78%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NeuroPace Short Interest DataNeuroPace (NPCE) has a short interest of 437,900 shares, representing 3.26% of the float (the number of shares available for trading by the public). This marks a -14.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.3, indicating that it would take 6.3 days of the average trading volume of 97,227 shares to cover all short positions.Current Short Interest437,900 sharesPrevious Short Interest509,200 sharesChange Vs. Previous Month-14.00%Dollar Volume Sold Short$2.82 millionShort Interest Ratio6.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares29,850,000 sharesFloat Size13,420,000 sharesShort Percent of Float3.26%Today's Trading Volume67,025 sharesAverage Trading Volume97,227 sharesToday's Volume Vs. Average69% Short Selling NeuroPace? Sign up to receive the latest short interest report for NeuroPace and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNPCE Short Interest Over TimeNPCE Days to Cover Over TimeNPCE Percentage of Float Shorted Over Time Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. NeuroPace Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024437,900 shares $2.82 million -14.0%3.3%6.3 $6.45 10/15/2024509,200 shares $3.29 million -4.5%3.5%9 $6.46 9/30/2024532,900 shares $3.71 million +5.2%3.7%8.8 $6.97 9/15/2024506,400 shares $3.76 million -2.2%3.5%5.6 $7.43 8/31/2024517,800 shares $4.10 million +6.0%3.7%5.4 $7.92 8/15/2024488,300 shares $3.46 million +2.1%3.4%4.6 $7.10 Get the Latest News and Ratings for NPCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024478,400 shares $3.70 million +8.8%3.4%4.2 $7.73 7/15/2024439,700 shares $3.39 million +223.8%3.1%3.6 $7.70 6/30/2024135,800 shares $1.03 million +56.6%1.0%1 $7.56 6/15/202486,700 shares $560,082.00 +16.9%0.6%0.8 $6.46 5/31/202474,200 shares $512,722.00 -40.9%0.5%0.7 $6.91 5/15/2024125,500 shares $1.13 million +39.8%0.9%1.1 $9.03 4/30/202489,800 shares $1.17 million -7.5%0.7%0.8 $12.99 4/15/202497,100 shares $1.30 million +13.0%0.7%0.9 $13.40 3/31/202485,900 shares $1.13 million +178.0%0.7%0.9 $13.20 3/15/202430,900 shares $407,262.00 -38.6%0.3%0.3 $13.18 2/29/202450,300 shares $813,351.00 -19.8%0.4%0.6 $16.17 2/15/202462,700 shares $1.01 million -0.5%0.6%0.7 $16.08 1/31/202463,000 shares $921,060.00 +76.0%0.6%0.8 $14.62 1/15/202435,800 shares $410,626.00 -43.6%0.3%0.4 $11.47 12/31/202363,500 shares $654,685.00 -32.5%0.6%0.9 $10.31 12/15/202394,100 shares $852,546.00 -26.9%0.9%1.6 $9.06 11/30/2023128,800 shares $1.16 million -14.7%1.2%2.2 $8.99 11/15/2023151,000 shares $1.31 million -61.8%1.4%2.2 $8.70 10/31/2023395,600 shares $2.67 million +26.4%3.7%4.5 $6.75 10/15/2023313,100 shares $1.88 million +2.0%3.0%3.9 $6.01 9/30/2023307,100 shares $2.99 million -12.8%2.9%4.1 $9.73 9/15/2023352,200 shares $3.05 million -20.2%3.3%4.9 $8.66 8/31/2023441,100 shares $4.14 million -7.8%4.3%6.7 $9.39 8/15/2023478,400 shares $2.15 million +1.3%4.6%14.2 $4.50 7/31/2023472,400 shares $1.96 million +0.5%4.7%26.1 $4.15 7/15/2023470,000 shares $1.97 million -0.8%5.1%37 $4.19 6/30/2023474,000 shares $2.13 million +2.5%5.2%30.4 $4.49 6/15/2023462,500 shares $2.08 million -0.3%5.0%27.4 $4.50 5/31/2023464,000 shares $2.06 million -1.0%5.6%27.5 $4.45 5/15/2023468,800 shares $1.92 million +0.2%5.7%19.2 $4.10 4/30/2023467,700 shares $2.34 million -27.0%5.6%17.7 $5.00 4/15/2023640,800 shares $3.08 million -0.7%7.8%25.6 $4.80 3/31/2023645,600 shares $3.00 million +1.3%8.0%22.4 $4.64 3/15/2023637,400 shares $2.17 million +0.4%7.9%9.8 $3.40Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 2/28/2023635,000 shares $3.26 million +1.0%7.9%9.5 $5.13 2/15/2023628,500 shares $2.93 million -2.3%7.9%9 $4.66 1/31/2023643,000 shares $3.01 million +7.4%7.5%6.2 $4.68 1/15/2023598,500 shares $2.03 million +0.5%6.9%5.7 $3.40 12/30/2022595,300 shares $886,997.00 -0.2%6.9%5.8 $1.49 12/15/2022596,700 shares $948,753.00 -1.7%6.9%5.9 $1.59 11/30/2022606,700 shares $976,787.00 -3.0%7.1%8.9 $1.61 11/15/2022625,500 shares $1.22 million +2.0%7.0%9.4 $1.95 10/31/2022613,300 shares $1.84 million +0.3%7.0%25.1 $3.00 10/15/2022611,700 shares $1.93 million -1.0%7.0%23.3 $3.15 9/30/2022618,100 shares $2.32 million -0.6%20.6%23.1 $3.75 9/15/2022621,500 shares $2.52 million -1.1%20.7%14.2 $4.05 8/31/2022628,200 shares $2.67 million No Change20.9%12.2 $4.25 8/15/2022628,200 shares $3.46 million -1.8%19.5%11.5 $5.50 7/31/2022639,500 shares $3.75 million -1.1%21.3%10.5 $5.86 7/15/2022646,300 shares $3.71 million -3.5%21.5%9.4 $5.74 6/30/2022669,700 shares $3.32 million -23.6%25.5%9.3 $4.95 6/15/2022876,100 shares $5.26 million -0.3%33.3%12.3 $6.00 5/31/2022878,600 shares $5.47 million +3.2%35.0%15.7 $6.23 5/15/2022851,000 shares $5.23 million +7.8%33.9%14.6 $6.15 4/30/2022789,300 shares $6.35 million +6.4%35.7%13.7 $8.04 4/15/2022742,200 shares $6.31 million -0.3%33.6%12.6 $8.50 3/31/2022744,400 shares $6.11 million +4.9%36.1%12.6 $8.21 3/15/2022709,600 shares $5.34 million +9.6%34.5%11.2 $7.52 2/28/2022647,600 shares $5.05 million +1.2%27.4%10.1 $7.80 2/15/2022639,800 shares $5.40 million +3.1%27.2%9.8 $8.44 1/31/2022620,400 shares $5.00 million -3.2%8.1%8.6 $8.06 1/15/2022640,600 shares $6.64 million -10.8%8.4%9.7 $10.36 12/31/2021718,500 shares $7.24 million +0.9%9.8%11.5 $10.08 12/15/2021712,300 shares $6.35 million -4.5%9.7%13.5 $8.92 11/30/2021745,700 shares $7.46 million -0.7%10.2%12.6 $10.00 11/15/2021750,800 shares $9.63 million -6.2%10.2%13.3 $12.83 10/29/2021800,400 shares $12.13 million -7.6%10.9%15.2 $15.16 10/15/2021865,900 shares $13.57 million +1.3%11.8%17.3 $15.67 9/30/2021854,600 shares $13.55 million +27.3%12.7%16.2 $15.85 9/15/2021671,400 shares $11.78 million +6.5%10.0%9.4 $17.54 8/31/2021630,400 shares $13.39 million +4.2%9.4%7.6 $21.24 8/13/2021605,200 shares $12.44 million No Change9.0%7 $20.55 NPCE Short Interest - Frequently Asked Questions What is NeuroPace's current short interest? Short interest is the volume of NeuroPace shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 437,900 shares of NPCE short. 3.26% of NeuroPace's shares are currently sold short. Learn More on NeuroPace's current short interest. What is a good short interest ratio for NeuroPace? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NPCE shares currently have a short interest ratio of 6.0. Learn More on NeuroPace's short interest ratio. What is a good short interest percentage for NeuroPace? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.26% of NeuroPace's floating shares are currently sold short. Is NeuroPace's short interest increasing or decreasing? NeuroPace saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 437,900 shares, a drop of 14.0% from the previous total of 509,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NeuroPace's float size? NeuroPace currently has issued a total of 29,850,000 shares. Some of NeuroPace's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroPace currently has a public float of 13,420,000 shares. How does NeuroPace's short interest compare to its competitors? 3.26% of NeuroPace's shares are currently sold short. Here is how the short interest of companies compare to NeuroPace: Utah Medical Products, Inc. (1.75%), TELA Bio, Inc. (1.22%), Beyond Air, Inc. (2.01%), PAVmed Inc. (3.25%), Pulse Biosciences, Inc. (14.85%), National Vision Holdings, Inc. (6.72%), Paragon 28, Inc. (17.50%), Liquidia Co. (12.21%), Avanos Medical, Inc. (1.35%), Embecta Corp. (3.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short NeuroPace stock? Short selling NPCE is an investing strategy that aims to generate trading profit from NeuroPace as its price is falling. NPCE shares are trading up $0.70 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NeuroPace? A short squeeze for NeuroPace occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NPCE, which in turn drives the price of the stock up even further. How often is NeuroPace's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NPCE, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies UTMD Short Interest Data TELA Short Interest Data XAIR Short Interest Data PAVM Short Interest Data PLSE Short Interest Data EYE Short Interest Data FNA Short Interest Data LQDA Short Interest Data AVNS Short Interest Data EMBC Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NPCE) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroPace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NPCE Stock Alerts